WO2010103140A3 - Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna - Google Patents
Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna Download PDFInfo
- Publication number
- WO2010103140A3 WO2010103140A3 PCT/ES2010/000097 ES2010000097W WO2010103140A3 WO 2010103140 A3 WO2010103140 A3 WO 2010103140A3 ES 2010000097 W ES2010000097 W ES 2010000097W WO 2010103140 A3 WO2010103140 A3 WO 2010103140A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- faeces
- breast milk
- characterisation
- strains
- isolation
- Prior art date
Links
- 230000000529 probiotic effect Effects 0.000 title abstract 3
- 210000003608 fece Anatomy 0.000 title abstract 2
- 210000004251 human milk Anatomy 0.000 title abstract 2
- 235000020256 human milk Nutrition 0.000 title abstract 2
- 238000012512 characterization method Methods 0.000 title 1
- 238000002955 isolation Methods 0.000 title 1
- 244000005700 microbiome Species 0.000 abstract 3
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 abstract 3
- 241000186012 Bifidobacterium breve Species 0.000 abstract 1
- 241000186605 Lactobacillus paracasei Species 0.000 abstract 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 235000013350 formula milk Nutrition 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 239000006041 probiotic Substances 0.000 abstract 1
- 235000018291 probiotics Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/519—Breve
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pediatric Medicine (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
Abstract
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/255,842 US8637297B2 (en) | 2009-03-10 | 2010-03-09 | Isolation, identification and characterization of strains with probiotic activity, from faeces of infants fed exclusively with breast milk |
PL10750390T PL2407532T3 (pl) | 2009-03-10 | 2010-03-09 | Izolowanie, identyfikacja i charakteryzowanie szczepów o działaniu probiotycznym pochodzących z kału niemowląt karmionych wyłącznie mlekiem matki |
EP10750390.6A EP2407532B1 (en) | 2009-03-10 | 2010-03-09 | Isolation, identification and characterisation of strains with probiotic activity, from faeces of infants fed exclusively with breast milk |
DK10750390.6T DK2407532T3 (en) | 2009-03-10 | 2010-03-09 | Isolation, identification and characterization of strains with probiotic activity from the faeces of infants exclusively fed with human breast milk |
ES10750390.6T ES2532095T3 (es) | 2009-03-10 | 2010-03-09 | Aislamiento, identificacion y caracterizacion de cepas con actividad probiotica a partir de heces de lactantes alimentados exclusivamente con leche materna |
CN201080020442.2A CN102421889B (zh) | 2009-03-10 | 2010-03-09 | 来自完全以母乳喂养的婴儿粪便的具有益生活性的菌株的分离、鉴定和表征 |
RU2011138363/10A RU2551315C2 (ru) | 2009-03-10 | 2010-03-09 | Выделение, идентификация и характеристика штаммов с пробиотической активностью, выделенных из фекалий детей, вскармливаемых исключительно материнским молоком |
US13/841,604 US20130280790A1 (en) | 2009-03-10 | 2013-03-15 | Isolation, identification and characterisation of strains with probiotic activity, from faeces of infants fed exclusively with breast milk |
US13/841,135 US20130280789A1 (en) | 2009-03-10 | 2013-03-15 | Isolation, identification and characterisation of strains with probiotic activity, from faeces of infants fed exclusively with breast milk |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/ES2009/000130 WO2010103132A1 (es) | 2009-03-10 | 2009-03-10 | Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna |
ESPCT/ES09/000130 | 2009-03-10 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/841,604 Division US20130280790A1 (en) | 2009-03-10 | 2013-03-15 | Isolation, identification and characterisation of strains with probiotic activity, from faeces of infants fed exclusively with breast milk |
US13/841,135 Division US20130280789A1 (en) | 2009-03-10 | 2013-03-15 | Isolation, identification and characterisation of strains with probiotic activity, from faeces of infants fed exclusively with breast milk |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010103140A2 WO2010103140A2 (es) | 2010-09-16 |
WO2010103140A3 true WO2010103140A3 (es) | 2010-11-04 |
Family
ID=42727821
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/ES2009/000130 WO2010103132A1 (es) | 2009-03-10 | 2009-03-10 | Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna |
PCT/ES2010/000097 WO2010103140A2 (es) | 2009-03-10 | 2010-03-09 | Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/ES2009/000130 WO2010103132A1 (es) | 2009-03-10 | 2009-03-10 | Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna |
Country Status (8)
Country | Link |
---|---|
US (3) | US8637297B2 (es) |
EP (3) | EP2848681B1 (es) |
CN (3) | CN104232544B (es) |
DK (3) | DK2407532T3 (es) |
ES (3) | ES2532095T3 (es) |
PL (3) | PL2848682T3 (es) |
RU (1) | RU2551315C2 (es) |
WO (2) | WO2010103132A1 (es) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2453591C1 (ru) * | 2011-04-21 | 2012-06-20 | Общество с ограниченной ответственностью "Бифилюкс" | Штамм lactobacillus rhamnosus, используемый для получения продукции, содержащей лактобактерии |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
CN101679938B (zh) * | 2007-03-28 | 2014-03-19 | 营养健康有限公司 | 益生双歧杆菌菌株 |
RU2013109251A (ru) | 2010-08-04 | 2014-09-10 | Томас Джулиус БОРОДИ | Композиции для трансплантации фекальной флоры и способы их получения и применения и устройства для их доставки |
US9968638B2 (en) | 2011-03-09 | 2018-05-15 | Regents Of The University Of Minnesota | Compositions and methods for transplantation of colon microbiota |
KR101228035B1 (ko) * | 2011-06-29 | 2013-01-30 | 주식회사 쎌바이오텍 | 신규한 유산균 및 이를 포함하는 당뇨병 예방 및 치료용 조성물 |
US9719144B2 (en) | 2012-05-25 | 2017-08-01 | Arizona Board Of Regents | Microbiome markers and therapies for autism spectrum disorders |
MX2015005898A (es) * | 2012-11-12 | 2016-02-05 | Gervais Danone Sa | Uso de una cepa de lactobacillus rhamnosus para reducir la ganancia de peso o la resistencia a la insulina, o ambas cosas al mismo tiempo. |
ES2468040B1 (es) * | 2012-11-13 | 2014-12-26 | Instituto Nacional De Investigación Y Tecnología Agraria Y Alimentaria (Inia) | Microorganismo aislado de leche materna y de heces de un lactante, y su uso como probiótico |
CN102960599A (zh) * | 2012-11-19 | 2013-03-13 | 陕西科技大学 | 一种含益生元的双歧杆菌微胶囊的制备方法 |
ITRM20130174A1 (it) * | 2013-03-22 | 2014-09-23 | Eurospital S P A | Ceppo di lactobacillus e suo uso come probiotico |
PL3030247T3 (pl) * | 2013-08-09 | 2019-02-28 | Ab-Biotics S.A. | Probiotyk na nadmierny płacz niemowlęcy |
ITMI20131467A1 (it) | 2013-09-06 | 2015-03-07 | Sofar Spa | Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico |
WO2015042683A1 (en) * | 2013-09-26 | 2015-04-02 | Hassan Firoozmand | Biopolymer compositions comprising a plurality of treated single-celled microorganisms |
EP3135753B1 (en) * | 2014-03-24 | 2019-12-25 | Otsuka Pharmaceutical Co., Ltd. | Novel lactobacillus paracasei strain |
MA39710A (fr) | 2014-04-23 | 2015-10-29 | Sofar Spa | Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin |
RU2605626C2 (ru) * | 2015-04-28 | 2016-12-27 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Кемеровский технологический институт пищевой промышленности (университет)" | Способ получения бактериального препарата с пробиотической активностью |
US9901603B2 (en) | 2015-05-14 | 2018-02-27 | Crestovo Holdings Llc | Compositions for fecal floral transplantation and methods for making and using them and device for delivering them |
JP6856968B2 (ja) | 2015-05-22 | 2021-04-14 | アリゾナ ボード オブ リージェンツ オン ビハーフ オブ アリゾナ ステート ユニバーシティ | 自閉症スペクトラム障害および関連する症候を治療するための方法 |
CN104894021B (zh) * | 2015-06-03 | 2018-02-09 | 宜兰食品工业股份有限公司 | 一种副干酪乳杆菌及其应用 |
CN105176822B (zh) * | 2015-10-23 | 2019-01-11 | 广州康泽医疗科技有限公司 | 一种人类肠道益生菌的优化分离方法 |
MA45288A (fr) | 2016-06-08 | 2019-04-17 | Sofar Spa | Nouvelle utilisation médicale de probiotiques |
US20170360848A1 (en) | 2016-06-15 | 2017-12-21 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods for treating autism spectrum disorder and associated symptoms |
US10849936B2 (en) | 2016-07-01 | 2020-12-01 | Regents Of The University Of Minnesota | Compositions and methods for C. difficile treatment |
US20180036352A1 (en) | 2016-08-03 | 2018-02-08 | Crestovo Holdings Llc | Methods for treating ulcerative colitis |
US11213549B2 (en) | 2016-10-11 | 2022-01-04 | Finch Therapeutics Holdings Llc | Compositions and method for treating primary sclerosing cholangitis and related disorders |
US10092601B2 (en) | 2016-10-11 | 2018-10-09 | Crestovo Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
WO2018071537A1 (en) | 2016-10-11 | 2018-04-19 | Crestovo Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
IT201600122724A1 (it) | 2016-12-02 | 2018-06-02 | Sofar Spa | Exopolysaccharides and uses thereof |
IT201600127498A1 (it) | 2016-12-16 | 2018-06-16 | Sofar Spa | Probiotici per uso nella diverticolosi e malattia diverticolare |
JP2020513018A (ja) | 2017-04-05 | 2020-04-30 | クレストヴォ・ホールディングス・エルエルシー | パーキンソン病(pd)および関連する障害を治療するための組成物および方法 |
US11040073B2 (en) | 2017-04-05 | 2021-06-22 | Finch Therapeutics Holdings Llc | Compositions and methods for treating diverticulitis and related disorders |
EP3630190B1 (en) | 2017-05-26 | 2024-02-21 | Finch Therapeutics Holdings LLC | Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same |
CN111328284A (zh) | 2017-08-07 | 2020-06-23 | 芬奇治疗公司 | 用于维持和恢复健康的肠道屏障的组合物和方法 |
EP3735130A4 (en) * | 2018-01-03 | 2022-02-16 | Evolve Biosystems, Inc. | METHOD FOR DETERMINING DYSBIosis IN THE INTESTINAL MICROBIOME |
US11938156B2 (en) * | 2018-01-05 | 2024-03-26 | Bened Biomedical Co., Ltd. | Lactic acid bacteria and its applications |
CN108315285A (zh) * | 2018-05-08 | 2018-07-24 | 西藏高原之宝牦牛乳业股份有限公司 | 一种副干酪乳杆菌及其制备方法 |
CN111164201B (zh) * | 2018-07-02 | 2023-09-12 | 葡萄王生技股份有限公司 | 用于改善代谢症候群的副干酪乳杆菌gks6、其用途、医药组合物及可食用组合物 |
US11166990B2 (en) | 2018-07-13 | 2021-11-09 | Finch Therapeutics Holdings Llc | Methods and compositions for treating ulcerative colitis |
CN109134628A (zh) * | 2018-09-26 | 2019-01-04 | 福建傲农生物科技集团股份有限公司 | 一种乳酸菌素plnE及其制备方法 |
KR20210065969A (ko) | 2018-09-27 | 2021-06-04 | 핀치 테라퓨틱스 홀딩스 엘엘씨 | 간질 및 관련 장애를 치료하기 위한 조성물 및 방법 |
CN109536415B (zh) * | 2018-12-26 | 2021-12-07 | 江西仁仁健康产业有限公司 | 一种鼠李糖乳杆菌及其应用 |
WO2020148391A1 (en) | 2019-01-16 | 2020-07-23 | N.V. Nutricia | Fermented formula with non-digestible oligosaccharides for use in rotavirus induced infection |
EP3924486A4 (en) * | 2019-02-14 | 2022-12-07 | Gutsybio Inc. | LIVING BIOTHERAPEUTICS FOR THE TREATMENT OF CARBOHYDRATE DISORDERS |
KR102139687B1 (ko) * | 2019-05-03 | 2020-07-30 | 주식회사 메디오젠 | 가드네렐라 바기날리스 및 칸디다 알비칸스에 항균 효과를 갖는 질염 치료 또는 개선용 유산균 mg4288 |
JP7013419B2 (ja) * | 2019-08-07 | 2022-02-15 | 日清食品ホールディングス株式会社 | 炎症性サイトカインの産生誘導活性は低いが抗炎症性サイトカインの産生誘導活性が高いビフィズス菌 |
US11751597B2 (en) | 2019-11-05 | 2023-09-12 | Alfasigma S.P.A. | Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems |
IT201900020422A1 (it) * | 2019-11-05 | 2021-05-05 | Sofar Spa | Composizioni comprendenti ceppi di batteri per uso per aumentare la biodisponibilità degli amminoacidi derivanti da proteine |
EP3725167A1 (en) * | 2019-11-11 | 2020-10-21 | COREE S.r.l. | Synergistic blends of probiotics expressing improved beneficial activity for human host favourably interacting with food, particularly baby food |
WO2021242057A1 (ko) * | 2020-05-28 | 2021-12-02 | 주식회사 바이오뱅크힐링 | 락토바실러스 속 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
KR102296286B1 (ko) * | 2020-06-16 | 2021-09-01 | 주식회사 바이오뱅크힐링 | 락토바실러스 람노서스 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
CN113817622B (zh) * | 2020-06-18 | 2023-05-26 | 青岛蔚蓝生物股份有限公司 | 一株具有减轻致癌物对人体细胞基因毒性作用的长双歧杆菌及其应用 |
CN111826312B (zh) * | 2020-07-10 | 2022-03-25 | 江南大学 | 一株可缓解苯并芘暴露的鼠李糖乳杆菌及其应用 |
CN111733110B (zh) * | 2020-07-17 | 2021-10-22 | 佛山市朗芯生物科技有限公司 | 副干酪乳杆菌及其在制备治疗溃疡性结肠炎药物中的应用 |
CN114317320B (zh) * | 2020-08-24 | 2022-12-27 | 汤臣倍健股份有限公司 | 一种短双歧杆菌207-1及其应用 |
CN113265351B (zh) * | 2021-05-11 | 2022-05-06 | 昆明理工大学 | 一株乳杆菌w8172及其应用 |
RU2766765C1 (ru) * | 2021-05-25 | 2022-03-15 | Федеральное государственное бюджетное учреждение "Детский научно-клинический центр инфекционных болезней Федерального медико-биологического агентства" | Способ лечения функциональных заболеваний желудочно-кишечного тракта у детей |
CN113322216B (zh) * | 2021-07-30 | 2021-11-05 | 北京量化健康科技有限公司 | 一种副干酪乳杆菌b111h及其在代谢综合征中的应用 |
KR102562507B1 (ko) * | 2021-12-08 | 2023-08-02 | 한국식품연구원 | 항염증 효과가 뛰어난 신규한 락토바실러스 파라카제이 아종 톨러란스 WiKim0148 및 이의 용도 |
CN114113023B (zh) * | 2021-12-16 | 2024-04-26 | 郑州轻工业大学 | 基于单核增生李斯特菌来源的氮掺杂碳点的制备方法和应用 |
CN114292779A (zh) * | 2021-12-22 | 2022-04-08 | 清远西周生物医药科技有限公司 | 一种副干酪乳杆菌冻干粉、其应用及制备方法 |
CN114381411B (zh) * | 2022-03-23 | 2022-05-27 | 山东中科嘉亿生物工程有限公司 | 乳酸乳球菌jyll-60及其在制备提高免疫力的产品上的应用 |
CN115998777B (zh) * | 2022-10-18 | 2023-11-17 | 汤臣倍健股份有限公司 | 副干酪乳杆菌207-27的用途 |
CN116731891B (zh) * | 2022-12-07 | 2024-05-07 | 内蒙古科拓生物有限公司 | 一株短双歧杆菌b2798及其制备益生菌制剂的用途 |
CN116855413B (zh) * | 2023-07-07 | 2024-02-09 | 镇江远森医药科技有限公司 | 利用鼠李糖乳杆菌YSs069制备调节人体微生态平衡的生物活性物质及其应用 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000067583A2 (en) * | 1999-05-07 | 2000-11-16 | Compagnie Gervais Danone | Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels |
EP1415656A1 (en) * | 1999-03-11 | 2004-05-06 | Société des Produits Nestlé S.A. | Lactobacillus strains capable of preventing diarrhoea caused by rotaviruses |
WO2006108824A1 (en) * | 2005-04-13 | 2006-10-19 | Nestec S.A. | Infant formula with probiotics |
WO2007125558A1 (en) * | 2006-05-03 | 2007-11-08 | Anidral S.R.L. | Symbiotic composition comprising non-digestible polysaccharides and bifidobacteria which metabolize them and its uses |
US20080187525A1 (en) * | 2007-02-01 | 2008-08-07 | Porubcan Randolph S | Formulations Including Digestive Enzymes and Polysorbate Surfactants that Enhance the Colonization of Administered Probiotics Microoganisms |
EP1974743A1 (en) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics to Improve Gut Microbiota |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE172245T1 (de) * | 1992-07-06 | 1998-10-15 | Nestle Sa | Milchbakterien |
PL195110B1 (pl) * | 1997-08-21 | 2007-08-31 | New Zealand Dairy Board | Biologicznie czyste kultury bakterii kwasu mlekowego Lactobacillus rhamnosus, kompozycje do immunostymulacji i zastosowanie biologicznie czystych kultur |
FI109602B (fi) * | 2001-01-25 | 2002-09-13 | Valio Oy | Probioottiyhdistelmä |
EP1384483A1 (en) * | 2002-07-23 | 2004-01-28 | Nestec S.A. | Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function |
JP4740866B2 (ja) * | 2003-10-24 | 2011-08-03 | ナムローゼ フェンノートシャップ ニュートリシア | 乳児向けシンバイオティック組成物 |
ITMI20042189A1 (it) * | 2004-11-16 | 2005-02-16 | Anidral Srl | Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale |
CN1259054C (zh) * | 2004-12-27 | 2006-06-14 | 孙文基 | 龙胆苦苷在制备抑制乙型肝炎病毒药物中的应用 |
US20100166721A1 (en) * | 2006-06-09 | 2010-07-01 | Fabiola Masri | Probotic compositions and uses thereof |
EP1997499A1 (en) * | 2007-05-31 | 2008-12-03 | Puleva Biotech, S.A. | Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis |
-
2009
- 2009-03-10 WO PCT/ES2009/000130 patent/WO2010103132A1/es active Application Filing
-
2010
- 2010-03-09 CN CN201410476564.2A patent/CN104232544B/zh not_active Expired - Fee Related
- 2010-03-09 US US13/255,842 patent/US8637297B2/en active Active
- 2010-03-09 EP EP14190638.8A patent/EP2848681B1/en not_active Not-in-force
- 2010-03-09 DK DK10750390.6T patent/DK2407532T3/en active
- 2010-03-09 CN CN201410478147.1A patent/CN104232545B/zh active Active
- 2010-03-09 ES ES10750390.6T patent/ES2532095T3/es active Active
- 2010-03-09 CN CN201080020442.2A patent/CN102421889B/zh active Active
- 2010-03-09 EP EP10750390.6A patent/EP2407532B1/en active Active
- 2010-03-09 PL PL14190648T patent/PL2848682T3/pl unknown
- 2010-03-09 EP EP14190648.7A patent/EP2848682B1/en active Active
- 2010-03-09 WO PCT/ES2010/000097 patent/WO2010103140A2/es active Application Filing
- 2010-03-09 ES ES14190638.8T patent/ES2632436T3/es active Active
- 2010-03-09 PL PL10750390T patent/PL2407532T3/pl unknown
- 2010-03-09 ES ES14190648.7T patent/ES2636944T3/es active Active
- 2010-03-09 PL PL14190638T patent/PL2848681T4/pl unknown
- 2010-03-09 RU RU2011138363/10A patent/RU2551315C2/ru active
- 2010-03-09 DK DK14190648.7T patent/DK2848682T3/en active
- 2010-03-09 DK DK14190638.8T patent/DK2848681T3/en active
-
2013
- 2013-03-15 US US13/841,135 patent/US20130280789A1/en not_active Abandoned
- 2013-03-15 US US13/841,604 patent/US20130280790A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1415656A1 (en) * | 1999-03-11 | 2004-05-06 | Société des Produits Nestlé S.A. | Lactobacillus strains capable of preventing diarrhoea caused by rotaviruses |
WO2000067583A2 (en) * | 1999-05-07 | 2000-11-16 | Compagnie Gervais Danone | Use of lactic acid bacteria in the preparation of fermented milks for the treatment of depressed immunity levels |
WO2006108824A1 (en) * | 2005-04-13 | 2006-10-19 | Nestec S.A. | Infant formula with probiotics |
WO2007125558A1 (en) * | 2006-05-03 | 2007-11-08 | Anidral S.R.L. | Symbiotic composition comprising non-digestible polysaccharides and bifidobacteria which metabolize them and its uses |
US20080187525A1 (en) * | 2007-02-01 | 2008-08-07 | Porubcan Randolph S | Formulations Including Digestive Enzymes and Polysorbate Surfactants that Enhance the Colonization of Administered Probiotics Microoganisms |
EP1974743A1 (en) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics to Improve Gut Microbiota |
Non-Patent Citations (3)
Title |
---|
MARTIN F-P J. ET AL.: "Top-down systems biology integration of conditional prebiotic modulated transgenomic interactions in a humanized microbiome mouse model.", MOLECULAR SYSTEMS BIOLOGY., vol. 4, no. 205, 15 July 2008 (2008-07-15), XP002680209 * |
SAAVEDRA J. M. ET AL.: "Use of probiotics in pediatrics: rationale, mechanisms of action and practical aspects.", NUTRITION IN CLINICAL PRACTICE., vol. 22, no. 3, June 2007 (2007-06-01), pages 351 - 365, XP009129949 * |
TIMMERMAN H. M. ET AL.: "Design of a multispecies probiotic mixture to prevent infectious complications in critically ill patients.", CLINICAL NUTRITION., vol. 26, 2007, pages 450 - 459, XP022159289 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2453591C1 (ru) * | 2011-04-21 | 2012-06-20 | Общество с ограниченной ответственностью "Бифилюкс" | Штамм lactobacillus rhamnosus, используемый для получения продукции, содержащей лактобактерии |
Also Published As
Publication number | Publication date |
---|---|
ES2632436T3 (es) | 2017-09-13 |
PL2848681T3 (pl) | 2017-10-31 |
EP2407532B1 (en) | 2014-12-10 |
CN104232544B (zh) | 2017-04-12 |
ES2532095T3 (es) | 2015-03-24 |
ES2636944T3 (es) | 2017-10-10 |
RU2551315C2 (ru) | 2015-05-20 |
US8637297B2 (en) | 2014-01-28 |
US20130280789A1 (en) | 2013-10-24 |
EP2407532A2 (en) | 2012-01-18 |
PL2407532T3 (pl) | 2015-06-30 |
CN102421889B (zh) | 2014-10-29 |
PL2848682T3 (pl) | 2017-12-29 |
EP2848682B1 (en) | 2017-05-31 |
DK2848682T3 (en) | 2017-09-11 |
EP2848681A1 (en) | 2015-03-18 |
EP2848681B1 (en) | 2017-04-12 |
EP2407532A4 (en) | 2013-04-10 |
PL2848681T4 (pl) | 2017-10-31 |
CN104232545A (zh) | 2014-12-24 |
US20130280790A1 (en) | 2013-10-24 |
DK2407532T3 (en) | 2015-03-09 |
US20120076829A1 (en) | 2012-03-29 |
WO2010103132A1 (es) | 2010-09-16 |
RU2011138363A (ru) | 2013-04-20 |
CN104232544A (zh) | 2014-12-24 |
CN104232545B (zh) | 2017-11-21 |
WO2010103140A2 (es) | 2010-09-16 |
CN102421889A (zh) | 2012-04-18 |
EP2848682A1 (en) | 2015-03-18 |
DK2848681T3 (en) | 2017-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010103140A3 (es) | Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna | |
Gupta et al. | Probiotics | |
MXPA04011664A (es) | Probioticos y tolerancia oral. | |
HK1160730A1 (en) | Probiotic infant products | |
CA2893822C (en) | Strain of bifidobacterium animalis ssp. animalis | |
SI3048165T1 (en) | NEW SEV BACTERIA BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS CECT 8145 AND ITS APPLICATION FOR INJURY AND / OR PREVENTION OF OVERVIEW OF BODY WEALTH AND BALANCE AND ASSOCIATED DISEASES | |
KR101487210B1 (ko) | 항알레르기용 조성물 | |
PT1359816E (pt) | Combinacao de probioticos | |
MY144315A (en) | Beta-galactosidase with transgalactosylating activity | |
RU2011122453A (ru) | Питательная композиция, включающая пробиотики и улучшающая характер сна | |
NZ593708A (en) | Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin | |
WO2011050426A3 (en) | New strains of lactic acid bacteria and their combinations producing probiotic preparations | |
HRP20210995T1 (hr) | Uporaba probiotika u liječenju i/ili prevenciji atopičnog dermatitisa | |
WO2009013709A3 (en) | Zinc-enriched biomass, method for the preparation thereof and pro-biotic, cosmetic, dietary and nutraceutic products comprising the same | |
GB2447006A (en) | Galactosidase with alph-galactosyltransferase activity | |
KR20130141350A (ko) | 상피 통과 저항성을 개선하기 위한 프로바이오틱 균주의 용도 | |
Arian et al. | Anti-proliferative effects of two new Lactobacillus strains of human origin on Caco-2 cell line | |
Agarwal et al. | Probiotics-A novel approach for health benefits | |
Agarwal | Probiotics--the health friendly gut bacteria. | |
MX2015010591A (es) | Composición de medio de cultivo para favorecer el desarrollo y crecimiento de los microorganismos probióticos lactobacillus plantarum y bifidobacterium animalis. | |
CZ22460U1 (cs) | Rýžový dezert s probiotiky | |
Lavryk | Characteristics of adhesive properties of lactobacillus-clinical isolates and components of biological products | |
Gomathy | Probiotics in Human Diet | |
RS20100436A2 (en) | Indigenous LACTOBACILLUS strains and their use as probiotics | |
CZ31860U1 (cs) | Probiotický jogurtový nápoj z mléka malých přežvýkavců s přídavkem přírodních prebiotik z jakonu |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201080020442.2 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10750390 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010750390 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2011138363 Country of ref document: RU Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13255842 Country of ref document: US |